Gerald L. Waneck

1.9k total citations
36 papers, 1.7k citations indexed

About

Gerald L. Waneck is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Gerald L. Waneck has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Immunology and 10 papers in Genetics. Recurrent topics in Gerald L. Waneck's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Virus-based gene therapy research (5 papers). Gerald L. Waneck is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Virus-based gene therapy research (5 papers). Gerald L. Waneck collaborates with scholars based in United States, Australia and Switzerland. Gerald L. Waneck's co-authors include Richard A. Flavell, Naomi Rosenberg, David H. Sherman, Douglas Brown, M G Low, Linda C. Burkly, Janet Stiernberg, Paul W. Kincade, Jörg D. Seebach and David B. Williams and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Gerald L. Waneck

35 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald L. Waneck United States 23 781 736 232 220 200 36 1.7k
Pnina Carmi Israel 21 853 1.1× 932 1.3× 283 1.2× 151 0.7× 143 0.7× 24 1.7k
Mark Renz United States 17 697 0.9× 1.5k 2.0× 228 1.0× 169 0.8× 261 1.3× 22 2.6k
Tanya L. Crockford United Kingdom 18 773 1.0× 799 1.1× 274 1.2× 240 1.1× 78 0.4× 26 1.8k
Catherine R. Ferenz United States 11 937 1.2× 1.2k 1.7× 260 1.1× 183 0.8× 124 0.6× 11 2.3k
Ji Zhao United States 15 591 0.8× 926 1.3× 110 0.5× 212 1.0× 70 0.3× 21 1.6k
Y Katsura Japan 19 890 1.1× 565 0.8× 261 1.1× 98 0.4× 80 0.4× 70 1.7k
Mary‐Pat Stein United States 12 492 0.6× 583 0.8× 106 0.5× 332 1.5× 120 0.6× 14 1.4k
Sarkis H. Ohanian United States 23 613 0.8× 529 0.7× 105 0.5× 101 0.5× 183 0.9× 75 1.3k
Els C.M. Brinkman-Van der Linden United States 17 618 0.8× 998 1.4× 116 0.5× 122 0.6× 276 1.4× 18 1.4k
G Limjuco United States 15 753 1.0× 839 1.1× 73 0.3× 84 0.4× 96 0.5× 21 1.5k

Countries citing papers authored by Gerald L. Waneck

Since Specialization
Citations

This map shows the geographic impact of Gerald L. Waneck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald L. Waneck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald L. Waneck more than expected).

Fields of papers citing papers by Gerald L. Waneck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald L. Waneck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald L. Waneck. The network helps show where Gerald L. Waneck may publish in the future.

Co-authorship network of co-authors of Gerald L. Waneck

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald L. Waneck. A scholar is included among the top collaborators of Gerald L. Waneck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald L. Waneck. Gerald L. Waneck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Musk, Gabrielle C., et al.. (2013). Laparoscopic Kidney Orthotopic Transplant: Preclinical Study in the Pig Model. Transplantation Proceedings. 45(5). 1776–1779. 7 indexed citations
2.
Waneck, Gerald L., et al.. (2013). Laparoscopic Surgery for Kidney Orthotopic Transplant in the Pig Model. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 17(1). 126–131. 17 indexed citations
3.
Keck, Tobias, Andrew L. Warshaw, Bozena Antoniu, et al.. (2005). Pancreatic proteases in serum induce leukocyte-endothelial adhesion and pancreatic microcirculatory failure. Pancreatology. 5(2-3). 241–250. 37 indexed citations
5.
Sharland, Alexandra F., et al.. (2002). Genetically Modified HLA Class I Molecules Able to Inhibit Human NK Cells Without Provoking Alloreactive CD8+ CTLs. The Journal of Immunology. 168(7). 3266–3274. 26 indexed citations
6.
Tikkanen, Ritva, et al.. (2002). The Receptor-Bound N-Terminal Ectodomain of the Amyloid Precursor Protein Is Associated with Membrane Rafts. Biological Chemistry. 383(12). 1855–64. 9 indexed citations
7.
Manilay, Jennifer O., Gerald L. Waneck, & Megan Sykes. (1999). Levels of Ly-49 Receptor Expression Are Determined by the Frequency of Interactions with MHC Ligands: Evidence Against Receptor Calibration to a “Useful” Level. The Journal of Immunology. 163(5). 2628–2633. 16 indexed citations
8.
Suh, Woong‐Kyung, et al.. (1996). MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains.. The Journal of Experimental Medicine. 184(2). 337–348. 92 indexed citations
9.
Cao, Wei, Lizi Wu, Ginger E. Exley, et al.. (1996). Sequence and transcription of Qa-2-encoding genes in mouse lymphocytes and blastocysts. Immunogenetics. 45(2). 97–107. 27 indexed citations
10.
Kurian, Marina, et al.. (1995). Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.. PubMed. 1(3). 343–9. 21 indexed citations
11.
Sadasivan, Bhanu, Annaiah Cariappa, Gerald L. Waneck, & Peter Cresswell. (1995). Assembly, Peptide Loading, and Transport of MHC Class I Molecules in a Calnexin-negative Cell Line. Cold Spring Harbor Symposia on Quantitative Biology. 60(0). 267–275. 71 indexed citations
12.
Kamitani, Tetsu, Hui‐Ming Chang, Carl T. Rollins, Gerald L. Waneck, & Edward T.H. Yeh. (1993). Correction of the class H defect in glycosylphosphatidylinositol anchor biosynthesis in Ltk- cells by a human cDNA clone.. Journal of Biological Chemistry. 268(28). 20733–20736. 76 indexed citations
13.
Low, M G, Janet Stiernberg, Gerald L. Waneck, Richard A. Flavell, & Paul W. Kincade. (1988). Cell-specific heterogeneity in sensitivity of phosphatidylinositol-anchored membrane antigens to release by phospholipase C. Journal of Immunological Methods. 113(1). 101–111. 139 indexed citations
14.
Sherman, David H., Gerald L. Waneck, & Richard A. Flavell. (1988). Qa-2 antigen encoded by Q7b is biochemically indistinguishable from Qa-2 expressed on the surface of C57BL/10 mouse spleen cells.. The Journal of Immunology. 140(1). 138–142. 16 indexed citations
15.
Waneck, Gerald L., et al.. (1988). Conversion of a PI-Anchored Protein to an Integral Membrane Protein by a Single Amino Acid Mutation. Science. 241(4866). 697–699. 67 indexed citations
16.
Waneck, Gerald L., et al.. (1987). Tissue-specific expression of cell-surface Qa-2 antigen from a transfected Q7b gene of C57BL/10 mice.. The Journal of Experimental Medicine. 165(5). 1358–1370. 60 indexed citations
17.
Waneck, Gerald L., et al.. (1986). Abelson virus drives the differentiation of harvey virus-infected erythroid cells. Cell. 44(2). 337–344. 30 indexed citations
18.
Wortis, Henry H., et al.. (1982). Lack of mature B cells in nude mice with X-linked immune deficiency.. The Journal of Experimental Medicine. 155(3). 903–913. 74 indexed citations
19.
Waneck, Gerald L. & Naomi Rosenberg. (1981). Ontogeny of Abelson Murine Leukemia Virus Target Cells. Hämatologie und Bluttransfusion. 26. 467–471.
20.
Tevethia, Satvir S., et al.. (1974). Requirement of thymus-derived theta-positive lymphocytes for rejection of DNA virus (SV 40) tumors in mice.. PubMed. 113(5). 1417–23. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026